ACADIAN ASSET MANAGEMENT LLC - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 23 filers reported holding ATYR PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q4 2022$57
-99.9%
26,419
+32.3%
0.00%
Q2 2022$57,000
-72.6%
19,963
-53.3%
0.00%
-100.0%
Q2 2021$208,000
-54.5%
42,724
-58.4%
0.00%
-50.0%
Q1 2021$457,000
+41.9%
102,697
+23.7%
0.00%
+100.0%
Q4 2020$322,000
+19.7%
83,0520.0%0.00%0.0%
Q3 2020$269,000
-10.9%
83,052
+22.2%
0.00%0.0%
Q2 2020$302,000
+182.2%
67,964
+122.3%
0.00%
Q3 2019$107,00030,5760.00%
Other shareholders
ATYR PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 282,420$1,511,0002.38%
Tikvah Management LLC 1,350,833$7,227,0002.31%
Stonepine Capital Management, LLC 601,580$3,218,0001.34%
VR Adviser, LLC 1,398,889$7,484,0001.21%
TANG CAPITAL MANAGEMENT LLC 1,113,453$5,957,0001.19%
Deep Track Capital, LP 1,028,515$5,503,0000.35%
FEDERATED HERMES, INC. 5,222,250$27,939,0000.06%
Alyeska Investment Group, L.P. 760,798$4,070,0000.04%
Ikarian Capital, LLC 37,017$197,0000.03%
Baker Brothers Advisors 625,000$3,344,0000.02%
View complete list of ATYR PHARMA INC shareholders